پديدآورندگان :
Mahmoudi Moghaddam Hadi h.mahmoudi4@yahoo.com Institute of Neuropharmacology , Beitollahi Hadi Institute of Neuropharmacology , Dehghannoudeh Gholamreza Institute of Neuropharmacology , forootanfar Hamid Institute of Neuropharmacology
كليدواژه :
topotecan , Drug , DNA interaction , Graphene
چكيده فارسي :
A main anti-cancer medicine is topotecan (TPT), which is a water-soluble derivative of
camptothecin. TPT is so effective for treatment of human ovarian cancer, cervical and small
cell lung cancer [1].Some methods have been applied to determine topotecan and only a few
voltammetric methods was used to study the electrochemical behavior of topotecan. The study
of interactions between drug and DNA is of present overall interest and importance, particularly
to design novel DNA-targeted medicines. Among the methods used to study the interaction
between DNA and drug, electrochemical techniques are particularly promising because of their
high sensitivity and selectivity along with reasonably low costs [2]. Graphene is a low-cost
substance with excellent mechanical, electrical and thermal features and it has been recently
considered considerably. Owing to mentioned features, graphene is a good alternative for using
in electrochemical biosensor [3].In current research, the interaction of topotecan with DNA is
investigated with a graphene paste electrode and in solution phase via DPV. Based on the
interaction between dsDNA and topotecan, topotecan was determined by a simple, fast, reliable,
and sensitive DNA biosensor. After optimizing the main experimental parameters, This DNAcoated
GPE was fabricated to evaluate its performance analytically. A linear dynamic range of
7.0×10-7– 9.0×10-5 M was obtained for topotecan. Ultimately, the proposed biosensor was
found to be capable of successfully analyzing human serum and urine samples.